Canada markets closed

Nabriva Therapeutics plc (NBRV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.1500+0.1800 (+6.06%)
At close: 4:00PM EST
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
No. of Analysts3133
Avg. Estimate-1-0.7-5.43-3.37
Low Estimate-1.1-0.7-6-4
High Estimate-0.8-0.7-4.9-2.6
Year Ago EPS-2.9-2.5-11.2-5.43
Revenue EstimateCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
No. of Analysts3143
Avg. Estimate1.34M910k4.41M16.34M
Low Estimate350k910k2.92M7.01M
High Estimate2.8M910k6M32M
Year Ago Sales333kN/A9.48M4.41M
Sales Growth (year/est)302.40%N/A-53.50%270.50%
Earnings History2019-12-302020-03-302020-06-292020-09-29
EPS Est.-3.32-2.64-1.6-0.97
EPS Actual-2.9-2.5-1.4-0.9
Difference0.420.140.20.07
Surprise %12.70%5.30%12.50%7.20%
EPS TrendCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
Current Estimate-1-0.7-5.43-3.37
7 Days Ago-1-0.7-5.43-3.37
30 Days Ago-1-0.7-5.43-3.37
60 Days Ago-0.1-0.07-0.53-0.35
90 Days Ago-0.1-0.07-0.51-0.33
EPS RevisionsCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNBRVIndustrySector(s)S&P 500
Current Qtr.65.50%N/AN/AN/A
Next Qtr.72.00%N/AN/AN/A
Current Year51.50%N/AN/AN/A
Next Year37.90%N/AN/AN/A
Next 5 Years (per annum)97.20%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A